1

Issue July/August 2013

a Zero Gravity Solutions Publication

N e w s l e t t e r

Harvey Kaye Chairman Richard Godwin CEO & President

John Wayne Kennedy Chief Science Officer & Founder

Patrick Kennedy

Senior Vice President, Investor Relations

Dr. Wagner Vendrame

Research & Development, Lead Scientist, University of Flori-­da, Homestead, FL

Neal R. Pellis, Ph.D.

Director, Division of Space Life Sciences at Universities Space Research Association (USRA)

Neil Talbot, Ph.D.

Fauna, Research & Development, USDA

Erik Forsberg, Ph.D.

Human Stem Cell Lead, WiCell

Todd Meyerrose, Ph.D.

Human Regenerative Medicine, based at NASA Ames Research Center

Andrew Koopman

Manager, New Venture Develop-­ment of NYU, Office of Industrial Liaison

Robert Corkery, Ph.D.

Scientist, KTH Royal Institute of Technology, Stockholm, Sweden

I want to thank everyone;; our shareholders, staff,

advisors and consultants, all of whom have

played an integral role in the accomplishments

we’ve made from our inception, until right now.

Over these past months we have finalized the

merger that created our public entity, (ZGSI.PK),

and completed the financial audit necessary to

commence trading. We have put in place a

highly qualified, deeply experienced

management team and assembled a top-notch

Scientific Advisory Board, comprised of some of

the most respected, forward-thinking scientists

related to plant, animal and non-embryonic

human stem cell work.

Several drivers relating to the International

Space Station (ISS) create a unique and timely

opportunity for our Company to be the first

zero-gravity biotech company developing

intellectual property translating to commercial

licensing to third parties, new varieties of

patentable plant, animal and human stem cells

with unique and beneficial characteristics only

achievable in long-term microgravity.

Among these drivers are national and

international agencies that are most eager to

demonstrate the commercial value of the billions

of dollars spent to build the ISS, the ISS being

named a “national lab” and the threat to the world

food crops from climate change, the depletion of

minerals and nutrients in soil throughout the world

and new, aggressive and resistant plant diseases.

The most important driver;; however, is the

commercialization of access to the ISS, which

uniquely positions ZGSI to utilize our six years of

NASA-enabled flight experiments to the ISS and

our years with NASA and space industry

involvement to accomplish our corporate goals.

We look forward to the coming months as we

execute our flight schedule to bring a variety of

projects to the ISS commencing early in 2014 and

continue to implement our strategy to create and

patent stem cells in microgravity, not just for

commercial purposes, but for the benefit of

humanity.

Richard Godwin, CEO & President

Zero Gravity Solutions, Inc.

2

Ask any one in the world what their

favorite fruit is and chances are

the answer will be the banana.

And deservedly so, it’s easy to peel,

easy to eat and travels well. Interestingly,

although there are dozens of available

varieties of most other fruits, when it

comes to bananas only one variety

accounts for 99% of the banana export

market, the Cavendish… and it is

under serious threat of extinction.

black sigatoka, is the soil-borne fungus

that is threatening to wipe out the world’s

banana crops. It is considered one of the

most destructive and devastating crop

diseases and the one that causes the

greatest economic impact in banana and

plantain crops. It is extremely difficult to

eradicate as the pathogen has developed

resistance to the fungicides, which are

typically used to prevent the disease. A

future without bananas is hard to

imagine, but will very possibly become a

reality in our lifetime without a

groundbreaking solution.

Our scientists at ZGSI along with our

academic and corporate partners are

pioneering new solutions, utilizing space-­

flight acquired non-GMO stem cells as

well as ground-based solutions using the

Company’s chemistry based technolo-­

gies to treat the disease and/or produce

a variety that is resistant to the black

sigatoka fungus that is threatening to

wipe them out.

Zero Gravity Solutions, Inc.

has made its official debut to

the commercial space industry

and the reception could not

have been more positive. We

attended and presented at

several prominent industry

trade conferences in May and

June including SpaceTech

and the National Space

Society’s (NSS) International

Space Development

Conference (ISDC) in

California. Cliff McMurray, the

ISDC 2013 Business Track

Chairman, stated in a

follow-up email to our CEO,

Richard Godwin, “I’d like to

extend our thanks for the

presentation you gave on the

business track. Your session

was one of the most exciting

on the track, as I overheard

more than one attendee say.”

Additionally, the official NSS

press release on the event

stated, “A number of

revolutionary developments

were announced at the

conference, including startling

recent advances in growing

stem cells in space and how

they can be used.”

The Huffington Post

featured an overview of our

SpaceTech

presentation along

with SpaceX in a

blog on their

website.

Overseas, we

presented at the

Harwell Oxford Venture

Fest 2013, where we were

nominated as one of their

“Future 50”, Oxfords’

brightest business stars

of the future and billed as

“the ones to watch.”

Additionally, we have

submitted responses to

governmental Requests For

Information (RFI’s) and have

been represented at various

SBIR conferences and other

venues aimed at securing

non-dilutive funding and

initial project partners. We

are anticipating continued

positive feedback and

solidifying our strategic

relationships at the next

upcoming high profile

industry trade shows.

These include

the 2nd

Annual ISS

Research &

Development

Conference in

Denver on

July 16th and the

NewSpace 2013 show in

San Jose, CA on July 25,

2013.

“Your session

was one of the

most exciting

on the track.”

The momentum continues

to build as our exposure

widens within the

industries of space,

finance, biotechnology,

science and agriculture as

well as among

governmental entities.

3

TECH TALK The Science Behind Our Technology

Although the science behind our IP for

creating and replicating stem cells in

space is complex, the scientific basis

underlying the technology can be

easily understood.

Since food crops and renewable

energy are among our initial projects,

this discussion will focus on plant stem

cells and how growing stem cells in

space is vastly different from growing

them on Earth.

In 4 billion years of life on Earth,

almost everything about the environ-­

ment has changed;; however, there has

always been ONE CONSTANT: All

life on Earth has formed within the

confines of 1G. To overcome gravity,

about 50% of the energy expended by

terrestrial-bound plants is dedicated to

structural support. By removing gravity

from the equation, plant cells in a

weightless environment react to this

relatively benign environmental change

by going into survival mode. The

excess of energy causes differential

gene expression, wherein normally

dormant genes within the cell are able

to express themselves. With these

dormant genes now expressing, the

plant is able to adapt quickly to a

changing environment and specific

stressors, such as disease or drought.

Directed SelectionTM is the process of

exposing the stem cell to a particular

stressor so that it may acquire unique

and beneficial functionalities.

We are changing the genome without

changing the DNA. These changes in

the genome of the plant are done

without the need for additive or

subtractive genomic engineering, thus

the plant is still natural only with

previously dormant genes now

expressed and is therefor considered

non-GMO.

A Message from the Chairman

Getting to know… JULIE BLOCH, Vice President, Communications

Julie has been with Zero Gravity Solutions, Inc. from its inception. She has been instrumental in helping to shape the company’s development and build the internal infrastructure necessary for a publicly traded company. As Vice President of Communications, Julie is spearheading the strategy for providing the Company’s voice, driving its image and creating our overall presence to the world in this emerging industry of zero gravity biotechnology. Julie has a been a resident of Boca Raton, Florida for over 20 years since graduating the University of Maryland, College Park with a Bachelors of Science degree in Journalism. She has been married for eight years has two daughters, ages 3 and 5. For any questions regarding our company communications, please contact Julie via phone (561) 416-0400 or email at jbloch@zerogsi.com.

It is a rare opportunity to be

associated not only with the

creation of a new company

based upon scientific

breakthroughs developed

over the last six years of

flying biological stem cell

projects to the International

Space Station (ISS), but

also to potentially create a

new industry, zero gravity

based biotechnology. First,

there was the

pharmaceutical industry,

then biotechnology and

now zero-gravity based

biotechnology.

Our company has a highly

focused business plan

utilizing our NASA Space

Act Agreement and the

expertise of our highly

experienced team of space

scientists, biologists and

stem cell pioneers as well

as sophisticated business

and operational executives

who understand how to

create shareholder value.

ZGSI’s platform technology

provides the means and

ability to commercialize

and monetize the

unprecedented opportunity

of utilizing the ISS and its

extended zero/microgravity

environment to develop

stem cells with unique

characteristics. We have

positioned our company

to implement the vision of the

pioneers who recognized the

potential of utilizing the ISS to

develop scientific break-­

throughs in plant, animal and

non-embryonic human stem

cells that can be patented

and licensed for commercial

use and revenue generation.

We look to the future with

excitement and enthusiasm

for what we can accomplish

and the advances that our

technology can achieve.

Harvey Kaye, Chairman

Zero Gravity Solutions, Inc.

4

ZGSI IN THE NEWS….

The Space Review, July 15, 2013 Stimulating Greater Use of the ISS

By: Jeff Foust

Space.com

Profits from Orbit: Breeding Stem Cells in Space, Interview with CEO Richard Godwin

The Huffington Post, June 5, 2013

End of Space Shuttle Saves World By: Anna-Leahy & Douglas Dechow

For the latest press releases, please see our website at: www.zerogravity.com

CALENDAR OF EVENTS

FOR 2013:

American Astronautical Society Annual ISS R&D Conference

July 16-July 18, 2013, Denver, CO

The Space Show, July 22, 2013 Live internet radio interview with ZGSI CEO Richard Godwin, Archived

New Space 2013 July 25-July 27, 2013, San Jose, CA

American Society for Gravitational & Space Research

November 3-November 8, 2013, Orlando, FL

Scan below

to “Like Us”

Be sure to subscribe

to our new ZEROGSI channel on:

Issue 01 July/August 2013